ProBiotix Health Plc (FRA:X90)

Germany · Delayed Price · Currency is EUR

0.0765

0.00 (0.00%)

Last updated: Oct 23, 2026, 3:25 PM CEST

Market Cap	17.00M +20.5%
Revenue (ttm)	3.13M +45.1%
Net Income	-1.41M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,218
Open	0.0915
Previous Close	0.0765
Day's Range	0.0765 - 0.0915
52-Week Range	0.0390 - 0.1020
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 9, 2026

About ProBiotix Health

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in Fe... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2012

Employees 12

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol X90

Financial Performance

In 2025, ProBiotix Health's revenue was 2.73 million, an increase of 45.09% compared to the previous year's 1.88 million. Losses were -1.23 million, 45.6% more than in 2024.

Financial numbers in GBP Financial Statements